A detailed history of Segall Bryant & Hamill, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 96,996 shares of NTRA stock, worth $16.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
96,996
Previous 168,007 42.27%
Holding current value
$16.2 Million
Previous $18.2 Million 32.24%
% of portfolio
0.17%
Previous 0.33%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$97.75 - $129.67 $6.94 Million - $9.21 Million
-71,011 Reduced 42.27%
96,996 $12.3 Million
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $389,814 - $514,694
4,571 Added 2.8%
168,007 $18.2 Million
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $1.34 Million - $2.11 Million
22,689 Added 16.12%
163,436 $14.9 Million
Q4 2023

Feb 14, 2024

SELL
$37.55 - $62.64 $13,968 - $23,302
-372 Reduced 0.26%
140,747 $8.82 Million
Q3 2023

Nov 09, 2023

SELL
$43.4 - $62.52 $40,709 - $58,643
-938 Reduced 0.66%
141,119 $6.24 Million
Q2 2023

Aug 11, 2023

BUY
$47.08 - $55.16 $25,894 - $30,337
550 Added 0.39%
142,057 $6.91 Million
Q1 2023

May 15, 2023

BUY
$36.57 - $58.29 $63,595 - $101,366
1,739 Added 1.24%
141,507 $7.86 Million
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $327,963 - $459,840
9,598 Added 7.37%
139,768 $5.61 Million
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $93,949 - $144,193
2,544 Added 1.99%
130,170 $5.71 Million
Q2 2022

Aug 15, 2022

BUY
$28.13 - $44.54 $1.05 Million - $1.66 Million
37,207 Added 41.15%
127,626 $4.52 Million
Q1 2022

May 13, 2022

SELL
$30.32 - $91.33 $14,978 - $45,117
-494 Reduced 0.54%
90,419 $3.68 Million
Q4 2021

Feb 14, 2022

BUY
$86.26 - $119.0 $354,011 - $488,376
4,104 Added 4.73%
90,913 $8.49 Million
Q3 2021

Nov 03, 2021

BUY
$100.17 - $126.36 $225,182 - $284,057
2,248 Added 2.66%
86,809 $9.67 Million
Q2 2021

Aug 12, 2021

BUY
$86.05 - $119.72 $389,290 - $541,613
4,524 Added 5.65%
84,561 $9.6 Million
Q1 2021

May 13, 2021

SELL
$91.47 - $124.36 $124,033 - $168,632
-1,356 Reduced 1.67%
80,037 $8.13 Million
Q4 2020

Feb 12, 2021

SELL
$66.66 - $111.74 $1.81 Million - $3.03 Million
-27,149 Reduced 25.01%
81,393 $8.1 Million
Q3 2020

Nov 13, 2020

BUY
$45.89 - $72.67 $3.55 Million - $5.62 Million
77,314 Added 247.58%
108,542 $7.84 Million
Q2 2020

Aug 14, 2020

BUY
$26.36 - $49.86 $282,869 - $535,047
10,731 Added 52.35%
31,228 $1.56 Million
Q1 2020

May 14, 2020

BUY
$17.27 - $40.17 $353,983 - $823,364
20,497 New
20,497 $612,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.